166 related articles for article (PubMed ID: 26207917)
61. TP53 codon 72 polymorphism in susceptibility, overall survival, and adjuvant therapy response of gliomas.
Lima-Ramos V; Pacheco-Figueiredo L; Costa S; Pardal F; Silva A; Amorim J; Lopes JM; Reis RM
Cancer Genet Cytogenet; 2008 Jan; 180(1):14-9. PubMed ID: 18068527
[TBL] [Abstract][Full Text] [Related]
62. Identification of retinol binding protein 1 promoter hypermethylation in isocitrate dehydrogenase 1 and 2 mutant gliomas.
Chou AP; Chowdhury R; Li S; Chen W; Kim AJ; Piccioni DE; Selfridge JM; Mody RR; Chang S; Lalezari S; Lin J; Sanchez DE; Wilson RW; Garrett MC; Harry B; Mottahedeh J; Nghiemphu PL; Kornblum HI; Mischel PS; Prins RM; Yong WH; Cloughesy T; Nelson SF; Liau LM; Lai A
J Natl Cancer Inst; 2012 Oct; 104(19):1458-69. PubMed ID: 22945948
[TBL] [Abstract][Full Text] [Related]
63. ZIP4 is a novel molecular marker for glioma.
Lin Y; Chen Y; Wang Y; Yang J; Zhu VF; Liu Y; Cui X; Chen L; Yan W; Jiang T; Hergenroeder GW; Fletcher SA; Levine JM; Kim DH; Tandon N; Zhu JJ; Li M
Neuro Oncol; 2013 Aug; 15(8):1008-16. PubMed ID: 23595627
[TBL] [Abstract][Full Text] [Related]
64. Methylation and expression patterns of tropomyosin-related kinase genes in different grades of glioma.
Palani M; Arunkumar R; Vanisree AJ
Neuromolecular Med; 2014 Sep; 16(3):529-39. PubMed ID: 24840578
[TBL] [Abstract][Full Text] [Related]
65. High frequency of the X-chromosome inactivation in young female patients with high-grade glioma.
Li G; Zhang Z; Jin T; Liang H; Tu Y; Gong L; Chen Z; Gao G
Diagn Pathol; 2013 Jun; 8():101. PubMed ID: 23782947
[TBL] [Abstract][Full Text] [Related]
66. The effect of galectin-3 genetic variants on the susceptibility and prognosis of gliomas in a Chinese population.
Chen HJ; Zheng ZC; Yuan BQ; Liu Z; Jing J; Wang SS
Neurosci Lett; 2012 Jun; 518(1):1-4. PubMed ID: 22465244
[TBL] [Abstract][Full Text] [Related]
67. Enhancer of Zeste 2 (EZH2) is up-regulated in malignant gliomas and in glioma stem-like cells.
Orzan F; Pellegatta S; Poliani PL; Pisati F; Caldera V; Menghi F; Kapetis D; Marras C; Schiffer D; Finocchiaro G
Neuropathol Appl Neurobiol; 2011 Jun; 37(4):381-94. PubMed ID: 20946108
[TBL] [Abstract][Full Text] [Related]
68. Assessing the association between EFEMP1 rs3791679 polymorphism and risk of glioma in a Chinese Han population.
Jiang N; Peng YP; Wang XY; Dou CW; He WM
Genet Mol Res; 2016 Aug; 15(3):. PubMed ID: 27706619
[TBL] [Abstract][Full Text] [Related]
69. Impact of four lncRNA polymorphisms (rs2151280, rs7763881, rs1136410, and rs3787016) on glioma risk and prognosis: A case-control study.
Deng Y; Zhou L; Li N; Wang M; Yao L; Dong S; Zhang M; Yang P; Hao Q; Wu Y; Lyu L; Jin T; Dai Z; Kang H
Mol Carcinog; 2019 Dec; 58(12):2218-2229. PubMed ID: 31489712
[TBL] [Abstract][Full Text] [Related]
70. Expression and clinical significance of microRNA-326 in human glioma miR-326 expression in glioma.
Wang S; Lu S; Geng S; Ma S; Liang Z; Jiao B
Med Oncol; 2013 Mar; 30(1):373. PubMed ID: 23292865
[TBL] [Abstract][Full Text] [Related]
71. Evaluation of Genetic Variants in MIR3142HG in Susceptibility to and Prognosis of Glioma.
Guo X; Zhang M; Li Q; Zhao J; Wang B; Wang J; Mao P; Song J
Am J Clin Oncol; 2020 Jan; 43(1):1-8. PubMed ID: 31513017
[TBL] [Abstract][Full Text] [Related]
72. ERCC1 polymorphisms and risk of adult glioma in a Chinese population: a hospital-based case-control study.
Zhang N; Lin LY; Zhu LL; Wu F; Wen H; Pan D; Huang YC; Chen DQ
Cancer Invest; 2012 Mar; 30(3):199-202. PubMed ID: 22201261
[TBL] [Abstract][Full Text] [Related]
73. IDH-mutant glioma specific association of rs55705857 located at 8q24.21 involves MYC deregulation.
Oktay Y; Ülgen E; Can Ö; Akyerli CB; Yüksel Ş; Erdemgil Y; Durası IM; Henegariu OI; Nanni EP; Selevsek N; Grossmann J; Erson-Omay EZ; Bai H; Gupta M; Lee W; Turcan Ş; Özpınar A; Huse JT; Sav MA; Flanagan A; Günel M; Sezerman OU; Yakıcıer MC; Pamir MN; Özduman K
Sci Rep; 2016 Jun; 6():27569. PubMed ID: 27282637
[TBL] [Abstract][Full Text] [Related]
74. Frequency variations in the methylated pattern of p73/p21 genes and chromosomal aberrations correlating with different grades of glioma among south Indian population.
Palani M; Devan S; Arunkumar R; Vanisree AJ
Med Oncol; 2011 Dec; 28 Suppl 1():S445-52. PubMed ID: 20844987
[TBL] [Abstract][Full Text] [Related]
75. Nuclear FABP7 immunoreactivity is preferentially expressed in infiltrative glioma and is associated with poor prognosis in EGFR-overexpressing glioblastoma.
Liang Y; Bollen AW; Aldape KD; Gupta N
BMC Cancer; 2006 Apr; 6():97. PubMed ID: 16623952
[TBL] [Abstract][Full Text] [Related]
76. The tumoral A genotype of the MGMT rs34180180 single-nucleotide polymorphism in aggressive gliomas is associated with shorter patients' survival.
Fogli A; Chautard E; Vaurs-Barrière C; Pereira B; Müller-Barthélémy M; Court F; Biau J; Pinto AA; Kémény JL; Khalil T; Karayan-Tapon L; Verrelle P; Costa BM; Arnaud P
Carcinogenesis; 2016 Feb; 37(2):169-176. PubMed ID: 26717998
[TBL] [Abstract][Full Text] [Related]
77. Role of ERCC1 promoter hypermethylation in drug resistance to cisplatin in human gliomas.
Chen HY; Shao CJ; Chen FR; Kwan AL; Chen ZP
Int J Cancer; 2010 Apr; 126(8):1944-1954. PubMed ID: 19626585
[TBL] [Abstract][Full Text] [Related]
78. MicroRNA-21 expression is associated with overall survival in patients with glioma.
Wu L; Li G; Feng D; Qin H; Gong L; Zhang J; Zhang Z
Diagn Pathol; 2013 Dec; 8():200. PubMed ID: 24326156
[TBL] [Abstract][Full Text] [Related]
79. Genetic variations in the homologous recombination repair pathway genes modify risk of glioma.
Zhang H; Liu Y; Zhou K; Zhou C; Zhou R; Cheng C; Wei Q; Lu D; Zhou L
J Neurooncol; 2016 Jan; 126(1):11-17. PubMed ID: 26514363
[TBL] [Abstract][Full Text] [Related]
80. CXCL12 G801A polymorphism and susceptibility to glioma: a case‑control study.
Chang SF; Li SL; Yang B; Yao KM; Miao RH; Liang GF; Zhang KM
Genet Mol Res; 2015 Dec; 14(4):17399-405. PubMed ID: 26782381
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
